Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
University of California, Irvine
Fate Therapeutics
Sichuan University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Guangzhou Institute of Respiratory Disease
Shenzhen Second People's Hospital
Hoosier Cancer Research Network
Northwestern University
Cancer Research UK
Roswell Park Cancer Institute